Eli Lilly
LLY
LLY
1,371 hedge funds and large institutions have $71.9B invested in Eli Lilly in 2017 Q4 according to their latest regulatory filings, with 206 funds opening new positions, 454 increasing their positions, 468 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
1% less capital invested
Capital invested by funds: $72.7B → $71.9B (-$737M)
2% less call options, than puts
Call options by funds: $521M | Put options by funds: $532M
3% less repeat investments, than reductions
Existing positions increased: 454 | Existing positions reduced: 468
Holders
1,371
Holding in Top 10
23
Calls
$521M
Puts
$532M
Top Buyers
| 1 | +$415M | |
| 2 | +$180M | |
| 3 | +$164M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$119M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$87.2M |
Top Sellers
| 1 | -$361M | |
| 2 | -$324M | |
| 3 | -$145M | |
| 4 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$141M |
| 5 |
JP Morgan Chase
New York
|
-$126M |